Approval · Notice of Compliance 5550 · 2004
EDECRIN: Notice of Compliance 5550
Issued October 7, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5550
- Date
- October 7, 2004
- Company
- Merck Frosst Canada & Cie, Merck Frosst Canada & Co.Kirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength
- Therapeutic class
- Saluretic-diuretic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EDECRIN | 02258528 | Marketed |
Medicinal ingredients
- ETHACRYNIC ACID 25 MG per TAB